NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/16/2025
Back to search
Official data from USPTO
CANCER FUND IMPACT INVESTMENTS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CANCER FUND IMPACT INVESTMENTS
ST13
US500000097684045Class
35, 36, 41, 42
Filing
97684045
Registration
8070823
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
12/17/2025
Trademark type
Word
Nice classes
35, 36, 41, 42
Filing date
11/18/2022
Registration date
12/16/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/16/2025
Last transaction
12/17/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
11/10/2022
First use in commerce
11/10/2022
Drawing code
4
Owner type
16
Owner location
Phoenix, AZ
Examiner
JENKINS JR,CHARLES L
Law office
M30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
CXO Advisors & Management, LLC
Representatives
Gary W. Newson NOBLITT & NEWSON, PLLC
Technical classification
Nice Classes
Class 35Class 36Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business development servicesproviding start-up support for businesses of others
Class 36
Providing impact investment fundsInvestment servicesasset acquisitionconsultationdevelopment and management services; financing services supporting the development and commercialization of innovations targeting cancer; Venture capital financing; Management of investment funds; Venture capital servicesproviding financing to emerging and start-up companies; Venture capital funding services to emerging and start-up companies in the medical and health care industry; Providing venture capitaldevelopment capitalprivate equity and investment funding; Venture capital funding services to emerging and start-up companies; private equity fund investment services; management of investment funds
Class 41
Education servicesproviding mentoringtutoringclasseswebinarsseminarsconferencesblogsonline articlesvideosworkshops in the field of businessbusiness developmentstartupsfinanceinvestingventure capital supporting the development and commercialization of innovations targeting cancer
Class 42
Application service provider (ASP) featuring web-based software for buildingmotivatingorganizingengagingmanaging a network of individuals supporting venture capital financing of cancer-related innovations
Publications
History of USPTO decisions and trademark events.
43 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
12/16/2025
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
11/17/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
10/20/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/20/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
10/20/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/20/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/25/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/25/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
07/25/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/28/2025
GNFR
FINAL REFUSAL E-MAILED
05/28/2025
CNFR
FINAL REFUSAL WRITTEN
05/28/2025
IUAA
USE AMENDMENT ACCEPTED
05/27/2025
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
04/11/2025
IUAF
USE AMENDMENT FILED
04/11/2025
EAAU
TEAS AMENDMENT OF USE RECEIVED
04/11/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/11/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/11/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/11/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
01/08/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
01/08/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/15/2024
GNRT
NON-FINAL ACTION E-MAILED
10/15/2024
CNRT
NON-FINAL ACTION WRITTEN
10/15/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/07/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/07/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/10/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/10/2024
ALIE
ASSIGNED TO LIE
09/10/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/16/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
01/16/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
01/16/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/16/2023
GNRT
NON-FINAL ACTION E-MAILED
10/16/2023
CNRT
NON-FINAL ACTION WRITTEN
10/16/2023
DOCK
ASSIGNED TO EXAMINER
08/31/2023
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
11/23/2022
IUAF
USE AMENDMENT FILED
11/23/2022
EAAU
TEAS AMENDMENT OF USE RECEIVED
11/22/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/22/2022
NWAP
NEW APPLICATION ENTERED
11/22/2022
Continuous trademark protection
Get notified about every new filing that threatens CANCER FUND IMPACT INVESTMENTS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.